nodes	percent_of_prediction	percent_of_DWPC	metapath
Penbutolol—coronary artery disease—atherosclerosis	0.909	1	CtDrD
Penbutolol—Arterial thrombosis—Niacin—atherosclerosis	0.00517	0.0759	CcSEcCtD
Penbutolol—Ache—Lovastatin—atherosclerosis	0.00351	0.0515	CcSEcCtD
Penbutolol—Ache—Simvastatin—atherosclerosis	0.00328	0.0482	CcSEcCtD
Penbutolol—Ache—Pravastatin—atherosclerosis	0.00297	0.0436	CcSEcCtD
Penbutolol—Laryngospasm—Niacin—atherosclerosis	0.00186	0.0274	CcSEcCtD
Penbutolol—Amnesia—Rosuvastatin—atherosclerosis	0.00148	0.0217	CcSEcCtD
Penbutolol—Amnesia—Lovastatin—atherosclerosis	0.00125	0.0184	CcSEcCtD
Penbutolol—Amnesia—Ezetimibe—atherosclerosis	0.00123	0.018	CcSEcCtD
Penbutolol—Amnesia—Simvastatin—atherosclerosis	0.00117	0.0172	CcSEcCtD
Penbutolol—Depression—Rosuvastatin—atherosclerosis	0.00107	0.0157	CcSEcCtD
Penbutolol—Amnesia—Pravastatin—atherosclerosis	0.00106	0.0155	CcSEcCtD
Penbutolol—Affect lability—Pravastatin—atherosclerosis	0.000979	0.0144	CcSEcCtD
Penbutolol—Mood swings—Pravastatin—atherosclerosis	0.000942	0.0138	CcSEcCtD
Penbutolol—Erectile dysfunction—Lovastatin—atherosclerosis	0.000937	0.0137	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.000927	0.0136	CcSEcCtD
Penbutolol—Erectile dysfunction—Ezetimibe—atherosclerosis	0.000919	0.0135	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.000884	0.013	CcSEcCtD
Penbutolol—Erectile dysfunction—Simvastatin—atherosclerosis	0.000876	0.0129	CcSEcCtD
Penbutolol—Depression—Simvastatin—atherosclerosis	0.000846	0.0124	CcSEcCtD
Penbutolol—Erectile dysfunction—Niacin—atherosclerosis	0.000804	0.0118	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.000799	0.0117	CcSEcCtD
Penbutolol—Erectile dysfunction—Pravastatin—atherosclerosis	0.000792	0.0116	CcSEcCtD
Penbutolol—Depression—Pravastatin—atherosclerosis	0.000764	0.0112	CcSEcCtD
Penbutolol—Sweating—Niacin—atherosclerosis	0.000747	0.011	CcSEcCtD
Penbutolol—Cough—Rosuvastatin—atherosclerosis	0.00073	0.0107	CcSEcCtD
Penbutolol—Alopecia—Lovastatin—atherosclerosis	0.000719	0.0106	CcSEcCtD
Penbutolol—Alopecia—Ezetimibe—atherosclerosis	0.000705	0.0104	CcSEcCtD
Penbutolol—Alopecia—Simvastatin—atherosclerosis	0.000673	0.00987	CcSEcCtD
Penbutolol—Alopecia—Niacin—atherosclerosis	0.000618	0.00907	CcSEcCtD
Penbutolol—Insomnia—Rosuvastatin—atherosclerosis	0.000617	0.00906	CcSEcCtD
Penbutolol—Alopecia—Pravastatin—atherosclerosis	0.000608	0.00893	CcSEcCtD
Penbutolol—Cough—Ezetimibe—atherosclerosis	0.000606	0.0089	CcSEcCtD
Penbutolol—Dyspepsia—Rosuvastatin—atherosclerosis	0.000601	0.00881	CcSEcCtD
Penbutolol—Pain—Rosuvastatin—atherosclerosis	0.000583	0.00856	CcSEcCtD
Penbutolol—Cough—Niacin—atherosclerosis	0.000531	0.00779	CcSEcCtD
Penbutolol—Insomnia—Lovastatin—atherosclerosis	0.000523	0.00768	CcSEcCtD
Penbutolol—Cough—Pravastatin—atherosclerosis	0.000523	0.00767	CcSEcCtD
Penbutolol—Dyspnoea—Lovastatin—atherosclerosis	0.000516	0.00757	CcSEcCtD
Penbutolol—Insomnia—Ezetimibe—atherosclerosis	0.000513	0.00753	CcSEcCtD
Penbutolol—Dyspepsia—Lovastatin—atherosclerosis	0.000509	0.00747	CcSEcCtD
Penbutolol—Dyspnoea—Ezetimibe—atherosclerosis	0.000506	0.00742	CcSEcCtD
Penbutolol—Dyspepsia—Ezetimibe—atherosclerosis	0.000499	0.00733	CcSEcCtD
Penbutolol—Fatigue—Lovastatin—atherosclerosis	0.000499	0.00732	CcSEcCtD
Penbutolol—Pain—Lovastatin—atherosclerosis	0.000494	0.00726	CcSEcCtD
Penbutolol—Asthenia—Rosuvastatin—atherosclerosis	0.00049	0.00718	CcSEcCtD
Penbutolol—Insomnia—Simvastatin—atherosclerosis	0.000489	0.00718	CcSEcCtD
Penbutolol—Fatigue—Ezetimibe—atherosclerosis	0.000489	0.00718	CcSEcCtD
Penbutolol—Pain—Ezetimibe—atherosclerosis	0.000485	0.00712	CcSEcCtD
Penbutolol—Dyspnoea—Simvastatin—atherosclerosis	0.000482	0.00708	CcSEcCtD
Penbutolol—Hyperhidrosis—Niacin—atherosclerosis	0.00048	0.00705	CcSEcCtD
Penbutolol—Dyspepsia—Simvastatin—atherosclerosis	0.000476	0.00699	CcSEcCtD
Penbutolol—Hyperhidrosis—Pravastatin—atherosclerosis	0.000473	0.00694	CcSEcCtD
Penbutolol—Diarrhoea—Rosuvastatin—atherosclerosis	0.000467	0.00685	CcSEcCtD
Penbutolol—Fatigue—Simvastatin—atherosclerosis	0.000466	0.00684	CcSEcCtD
Penbutolol—Pain—Simvastatin—atherosclerosis	0.000463	0.00679	CcSEcCtD
Penbutolol—Body temperature increased—Lovastatin—atherosclerosis	0.000457	0.00671	CcSEcCtD
Penbutolol—Dizziness—Rosuvastatin—atherosclerosis	0.000451	0.00662	CcSEcCtD
Penbutolol—Insomnia—Niacin—atherosclerosis	0.000449	0.00659	CcSEcCtD
Penbutolol—Body temperature increased—Ezetimibe—atherosclerosis	0.000448	0.00658	CcSEcCtD
Penbutolol—Dyspnoea—Niacin—atherosclerosis	0.000443	0.0065	CcSEcCtD
Penbutolol—Insomnia—Pravastatin—atherosclerosis	0.000442	0.00649	CcSEcCtD
Penbutolol—Dyspepsia—Niacin—atherosclerosis	0.000437	0.00642	CcSEcCtD
Penbutolol—Dyspnoea—Pravastatin—atherosclerosis	0.000436	0.0064	CcSEcCtD
Penbutolol—Dyspepsia—Pravastatin—atherosclerosis	0.00043	0.00632	CcSEcCtD
Penbutolol—Body temperature increased—Simvastatin—atherosclerosis	0.000428	0.00627	CcSEcCtD
Penbutolol—Headache—Rosuvastatin—atherosclerosis	0.000427	0.00627	CcSEcCtD
Penbutolol—Pain—Niacin—atherosclerosis	0.000425	0.00623	CcSEcCtD
Penbutolol—Fatigue—Pravastatin—atherosclerosis	0.000422	0.00619	CcSEcCtD
Penbutolol—Pain—Pravastatin—atherosclerosis	0.000418	0.00614	CcSEcCtD
Penbutolol—Asthenia—Lovastatin—atherosclerosis	0.000415	0.00609	CcSEcCtD
Penbutolol—Asthenia—Ezetimibe—atherosclerosis	0.000407	0.00597	CcSEcCtD
Penbutolol—Nausea—Rosuvastatin—atherosclerosis	0.000405	0.00595	CcSEcCtD
Penbutolol—Diarrhoea—Lovastatin—atherosclerosis	0.000396	0.00581	CcSEcCtD
Penbutolol—Body temperature increased—Niacin—atherosclerosis	0.000393	0.00576	CcSEcCtD
Penbutolol—Asthenia—Simvastatin—atherosclerosis	0.000388	0.00569	CcSEcCtD
Penbutolol—Diarrhoea—Ezetimibe—atherosclerosis	0.000388	0.00569	CcSEcCtD
Penbutolol—Body temperature increased—Pravastatin—atherosclerosis	0.000387	0.00567	CcSEcCtD
Penbutolol—Dizziness—Lovastatin—atherosclerosis	0.000382	0.00561	CcSEcCtD
Penbutolol—Dizziness—Ezetimibe—atherosclerosis	0.000375	0.0055	CcSEcCtD
Penbutolol—Diarrhoea—Simvastatin—atherosclerosis	0.00037	0.00543	CcSEcCtD
Penbutolol—Headache—Lovastatin—atherosclerosis	0.000362	0.00532	CcSEcCtD
Penbutolol—Dizziness—Simvastatin—atherosclerosis	0.000358	0.00525	CcSEcCtD
Penbutolol—Asthenia—Niacin—atherosclerosis	0.000356	0.00523	CcSEcCtD
Penbutolol—Headache—Ezetimibe—atherosclerosis	0.000355	0.00521	CcSEcCtD
Penbutolol—Asthenia—Pravastatin—atherosclerosis	0.000351	0.00515	CcSEcCtD
Penbutolol—Nausea—Lovastatin—atherosclerosis	0.000343	0.00504	CcSEcCtD
Penbutolol—Diarrhoea—Niacin—atherosclerosis	0.00034	0.00499	CcSEcCtD
Penbutolol—Headache—Simvastatin—atherosclerosis	0.000339	0.00497	CcSEcCtD
Penbutolol—Nausea—Ezetimibe—atherosclerosis	0.000337	0.00494	CcSEcCtD
Penbutolol—Diarrhoea—Pravastatin—atherosclerosis	0.000335	0.00491	CcSEcCtD
Penbutolol—Dizziness—Niacin—atherosclerosis	0.000328	0.00482	CcSEcCtD
Penbutolol—Dizziness—Pravastatin—atherosclerosis	0.000323	0.00475	CcSEcCtD
Penbutolol—Nausea—Simvastatin—atherosclerosis	0.000321	0.00471	CcSEcCtD
Penbutolol—Headache—Niacin—atherosclerosis	0.000311	0.00457	CcSEcCtD
Penbutolol—Headache—Pravastatin—atherosclerosis	0.000306	0.0045	CcSEcCtD
Penbutolol—Nausea—Niacin—atherosclerosis	0.000295	0.00433	CcSEcCtD
Penbutolol—Nausea—Pravastatin—atherosclerosis	0.00029	0.00426	CcSEcCtD
Penbutolol—ADRB1—GPCR downstream signaling—PRKCG—atherosclerosis	1.47e-05	0.000629	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CNR2—atherosclerosis	1.46e-05	0.000625	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—CXCL8—atherosclerosis	1.46e-05	0.000624	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CCR2—atherosclerosis	1.45e-05	0.000623	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—EDNRA—atherosclerosis	1.45e-05	0.000623	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—MMP3—atherosclerosis	1.45e-05	0.000623	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CYBA—atherosclerosis	1.45e-05	0.000621	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—PRKCG—atherosclerosis	1.44e-05	0.000616	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—PIK3CG—atherosclerosis	1.43e-05	0.000615	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CNR2—atherosclerosis	1.42e-05	0.000611	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—CXCL8—atherosclerosis	1.42e-05	0.00061	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—MMP3—atherosclerosis	1.42e-05	0.000609	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PARP1—atherosclerosis	1.42e-05	0.000608	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PLAT—atherosclerosis	1.42e-05	0.000608	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—GHRL—atherosclerosis	1.42e-05	0.000608	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—EDN1—atherosclerosis	1.41e-05	0.000606	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—PRKCG—atherosclerosis	1.4e-05	0.000602	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—CCL5—atherosclerosis	1.4e-05	0.000601	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—EDN1—atherosclerosis	1.38e-05	0.000593	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CCL5—atherosclerosis	1.37e-05	0.000588	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—F2—atherosclerosis	1.36e-05	0.000584	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—EDN1—atherosclerosis	1.35e-05	0.00058	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CCL5—atherosclerosis	1.34e-05	0.000575	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—PRKCG—atherosclerosis	1.33e-05	0.000572	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—VWF—atherosclerosis	1.33e-05	0.000569	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—APOC3—atherosclerosis	1.32e-05	0.000566	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—LDLR—atherosclerosis	1.31e-05	0.000562	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—PRKCG—atherosclerosis	1.3e-05	0.000559	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—PIK3CG—atherosclerosis	1.3e-05	0.000558	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—VWF—atherosclerosis	1.3e-05	0.000557	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—AGT—atherosclerosis	1.29e-05	0.000554	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—APOC3—atherosclerosis	1.29e-05	0.000553	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—LDLR—atherosclerosis	1.28e-05	0.00055	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CCL3—atherosclerosis	1.28e-05	0.000549	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—PRKCG—atherosclerosis	1.27e-05	0.000547	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—VWF—atherosclerosis	1.27e-05	0.000544	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—AGT—atherosclerosis	1.26e-05	0.000542	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—APOC3—atherosclerosis	1.26e-05	0.000541	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—LDLR—atherosclerosis	1.25e-05	0.000538	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CCL3—atherosclerosis	1.25e-05	0.000537	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—KNG1—atherosclerosis	1.24e-05	0.000533	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—AGTR1—atherosclerosis	1.24e-05	0.00053	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—AGT—atherosclerosis	1.24e-05	0.00053	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—NCF1—atherosclerosis	1.23e-05	0.000526	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CCL3—atherosclerosis	1.22e-05	0.000525	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—CCL2—atherosclerosis	1.21e-05	0.00052	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PLG—atherosclerosis	1.2e-05	0.000517	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—NCF1—atherosclerosis	1.2e-05	0.000514	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—F2—atherosclerosis	1.19e-05	0.000512	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—AGT—atherosclerosis	1.17e-05	0.000503	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—NCF1—atherosclerosis	1.17e-05	0.000503	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—F2—atherosclerosis	1.17e-05	0.000501	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—EDNRA—atherosclerosis	1.16e-05	0.000497	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CCR2—atherosclerosis	1.16e-05	0.000497	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CYBA—atherosclerosis	1.15e-05	0.000494	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—AGT—atherosclerosis	1.15e-05	0.000492	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—PIK3CG—atherosclerosis	1.14e-05	0.00049	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—F2—atherosclerosis	1.14e-05	0.000489	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—SOCS3—atherosclerosis	1.14e-05	0.000489	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CCR2—atherosclerosis	1.13e-05	0.000486	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—EDNRA—atherosclerosis	1.13e-05	0.000486	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PARP1—atherosclerosis	1.13e-05	0.000484	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—GHRL—atherosclerosis	1.13e-05	0.000484	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PLAT—atherosclerosis	1.13e-05	0.000484	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CYBA—atherosclerosis	1.13e-05	0.000484	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—AGT—atherosclerosis	1.12e-05	0.000481	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—PIK3CG—atherosclerosis	1.12e-05	0.000479	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CCR2—atherosclerosis	1.11e-05	0.000475	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—EDNRA—atherosclerosis	1.11e-05	0.000475	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PLAT—atherosclerosis	1.1e-05	0.000473	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PARP1—atherosclerosis	1.1e-05	0.000473	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—GHRL—atherosclerosis	1.1e-05	0.000473	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CYBA—atherosclerosis	1.1e-05	0.000473	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MMP3—atherosclerosis	1.1e-05	0.000473	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IGF2—atherosclerosis	1.1e-05	0.00047	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—PIK3CG—atherosclerosis	1.09e-05	0.000468	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—F2—atherosclerosis	1.08e-05	0.000465	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PLAT—atherosclerosis	1.08e-05	0.000463	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PARP1—atherosclerosis	1.08e-05	0.000463	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—GHRL—atherosclerosis	1.08e-05	0.000463	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—APOB—atherosclerosis	1.06e-05	0.000457	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—F2—atherosclerosis	1.06e-05	0.000455	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—CXCL8—atherosclerosis	1.06e-05	0.000453	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—EDN1—atherosclerosis	1.05e-05	0.000449	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CCL5—atherosclerosis	1.04e-05	0.000446	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—PIK3CG—atherosclerosis	1.04e-05	0.000445	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—F2—atherosclerosis	1.04e-05	0.000445	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—LPL—atherosclerosis	1.02e-05	0.000436	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—PIK3CG—atherosclerosis	1.01e-05	0.000435	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—PIK3CG—atherosclerosis	9.92e-06	0.000425	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—KNG1—atherosclerosis	9.9e-06	0.000425	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PRKCG—atherosclerosis	9.89e-06	0.000424	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—AGTR1—atherosclerosis	9.85e-06	0.000422	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—KNG1—atherosclerosis	9.69e-06	0.000415	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—CCL2—atherosclerosis	9.66e-06	0.000414	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—AGTR1—atherosclerosis	9.63e-06	0.000413	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—SPP1—atherosclerosis	9.63e-06	0.000413	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PLG—atherosclerosis	9.59e-06	0.000411	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—CXCL8—atherosclerosis	9.59e-06	0.000411	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—KNG1—atherosclerosis	9.47e-06	0.000406	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CCL2—atherosclerosis	9.45e-06	0.000405	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—AGTR1—atherosclerosis	9.42e-06	0.000404	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PLG—atherosclerosis	9.39e-06	0.000402	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CCL2—atherosclerosis	9.24e-06	0.000396	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PLG—atherosclerosis	9.18e-06	0.000394	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—SOCS3—atherosclerosis	9.09e-06	0.00039	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PDGFB—atherosclerosis	8.91e-06	0.000382	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—SOCS3—atherosclerosis	8.89e-06	0.000381	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MMP3—atherosclerosis	8.78e-06	0.000376	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IGF2—atherosclerosis	8.74e-06	0.000375	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—AGT—atherosclerosis	8.7e-06	0.000373	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—SOCS3—atherosclerosis	8.69e-06	0.000373	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MMP3—atherosclerosis	8.58e-06	0.000368	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IGF2—atherosclerosis	8.55e-06	0.000366	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—APOE—atherosclerosis	8.52e-06	0.000366	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—LEP—atherosclerosis	8.52e-06	0.000366	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—APOB—atherosclerosis	8.48e-06	0.000364	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CAV1—atherosclerosis	8.45e-06	0.000362	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—APOA1—atherosclerosis	8.43e-06	0.000361	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—CXCL8—atherosclerosis	8.41e-06	0.000361	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MMP3—atherosclerosis	8.39e-06	0.00036	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IGF2—atherosclerosis	8.36e-06	0.000358	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—EDN1—atherosclerosis	8.35e-06	0.000358	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—APOB—atherosclerosis	8.3e-06	0.000356	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CCL5—atherosclerosis	8.28e-06	0.000355	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—CXCL8—atherosclerosis	8.23e-06	0.000353	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—EDN1—atherosclerosis	8.16e-06	0.00035	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—ESR1—atherosclerosis	8.14e-06	0.000349	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—APOB—atherosclerosis	8.11e-06	0.000348	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CCL5—atherosclerosis	8.1e-06	0.000347	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—LPL—atherosclerosis	8.1e-06	0.000347	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—CXCL8—atherosclerosis	8.04e-06	0.000345	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—F2—atherosclerosis	8.04e-06	0.000345	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—EDN1—atherosclerosis	7.98e-06	0.000342	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—LPL—atherosclerosis	7.92e-06	0.00034	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CCL5—atherosclerosis	7.92e-06	0.00034	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PRKCG—atherosclerosis	7.87e-06	0.000338	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—LPL—atherosclerosis	7.75e-06	0.000332	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PRKCG—atherosclerosis	7.7e-06	0.00033	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PIK3CG—atherosclerosis	7.69e-06	0.00033	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—SPP1—atherosclerosis	7.67e-06	0.000329	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—CXCL8—atherosclerosis	7.64e-06	0.000327	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PRKCG—atherosclerosis	7.53e-06	0.000323	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—SPP1—atherosclerosis	7.5e-06	0.000322	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CXCL8—atherosclerosis	7.47e-06	0.00032	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—MAPK3—atherosclerosis	7.37e-06	0.000316	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—SPP1—atherosclerosis	7.34e-06	0.000315	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CXCL8—atherosclerosis	7.3e-06	0.000313	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—INS—atherosclerosis	7.28e-06	0.000312	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CCL2—atherosclerosis	7.16e-06	0.000307	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PDGFB—atherosclerosis	7.1e-06	0.000304	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IGF1—atherosclerosis	7.04e-06	0.000302	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PDGFB—atherosclerosis	6.94e-06	0.000298	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—AGT—atherosclerosis	6.93e-06	0.000297	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PDGFB—atherosclerosis	6.79e-06	0.000291	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—LEP—atherosclerosis	6.79e-06	0.000291	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—APOE—atherosclerosis	6.79e-06	0.000291	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—AGT—atherosclerosis	6.78e-06	0.000291	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CAV1—atherosclerosis	6.73e-06	0.000288	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—APOA1—atherosclerosis	6.71e-06	0.000288	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—SERPINE1—atherosclerosis	6.69e-06	0.000287	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—APOE—atherosclerosis	6.64e-06	0.000285	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—LEP—atherosclerosis	6.64e-06	0.000285	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—AGT—atherosclerosis	6.63e-06	0.000284	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CAV1—atherosclerosis	6.58e-06	0.000282	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—APOA1—atherosclerosis	6.56e-06	0.000282	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—APOE—atherosclerosis	6.49e-06	0.000278	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—LEP—atherosclerosis	6.49e-06	0.000278	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—ESR1—atherosclerosis	6.48e-06	0.000278	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CAV1—atherosclerosis	6.43e-06	0.000276	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—APOA1—atherosclerosis	6.42e-06	0.000275	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—F2—atherosclerosis	6.4e-06	0.000275	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—NOS3—atherosclerosis	6.39e-06	0.000274	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—ESR1—atherosclerosis	6.34e-06	0.000272	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—F2—atherosclerosis	6.26e-06	0.000269	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—ESR1—atherosclerosis	6.2e-06	0.000266	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PIK3CG—atherosclerosis	6.13e-06	0.000263	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—F2—atherosclerosis	6.12e-06	0.000263	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PIK3CG—atherosclerosis	5.99e-06	0.000257	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—MAPK3—atherosclerosis	5.87e-06	0.000252	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PIK3CG—atherosclerosis	5.86e-06	0.000251	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—INS—atherosclerosis	5.8e-06	0.000249	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—MAPK3—atherosclerosis	5.74e-06	0.000246	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CCL2—atherosclerosis	5.71e-06	0.000245	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—INS—atherosclerosis	5.67e-06	0.000243	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CXCL8—atherosclerosis	5.66e-06	0.000243	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—MAPK3—atherosclerosis	5.61e-06	0.000241	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IGF1—atherosclerosis	5.61e-06	0.000241	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CCL2—atherosclerosis	5.58e-06	0.000239	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—INS—atherosclerosis	5.55e-06	0.000238	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IGF1—atherosclerosis	5.49e-06	0.000235	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—AKT1—atherosclerosis	5.47e-06	0.000235	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CCL2—atherosclerosis	5.46e-06	0.000234	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—IL6—atherosclerosis	5.39e-06	0.000231	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IGF1—atherosclerosis	5.37e-06	0.00023	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—SERPINE1—atherosclerosis	5.33e-06	0.000228	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—SERPINE1—atherosclerosis	5.21e-06	0.000223	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MMP9—atherosclerosis	5.12e-06	0.00022	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—SERPINE1—atherosclerosis	5.1e-06	0.000218	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—NOS3—atherosclerosis	5.09e-06	0.000218	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—NFKB1—atherosclerosis	5.07e-06	0.000217	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MAPK8—atherosclerosis	4.98e-06	0.000214	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—NOS3—atherosclerosis	4.97e-06	0.000213	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—AKT1—atherosclerosis	4.97e-06	0.000213	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—NOS3—atherosclerosis	4.86e-06	0.000209	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—VEGFA—atherosclerosis	4.6e-06	0.000197	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—STAT3—atherosclerosis	4.56e-06	0.000195	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CXCL8—atherosclerosis	4.51e-06	0.000193	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CXCL8—atherosclerosis	4.41e-06	0.000189	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—AKT1—atherosclerosis	4.36e-06	0.000187	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MAPK3—atherosclerosis	4.35e-06	0.000187	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CXCL8—atherosclerosis	4.31e-06	0.000185	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—IL6—atherosclerosis	4.29e-06	0.000184	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—AKT1—atherosclerosis	4.26e-06	0.000183	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—TGFB1—atherosclerosis	4.22e-06	0.000181	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—IL6—atherosclerosis	4.2e-06	0.00018	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—AKT1—atherosclerosis	4.17e-06	0.000179	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—IL6—atherosclerosis	4.1e-06	0.000176	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MMP9—atherosclerosis	4.08e-06	0.000175	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—NFKB1—atherosclerosis	4.04e-06	0.000173	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MMP9—atherosclerosis	3.99e-06	0.000171	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MAPK8—atherosclerosis	3.97e-06	0.00017	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—AKT1—atherosclerosis	3.96e-06	0.00017	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—NFKB1—atherosclerosis	3.95e-06	0.000169	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MMP9—atherosclerosis	3.9e-06	0.000167	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MAPK8—atherosclerosis	3.88e-06	0.000166	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—AKT1—atherosclerosis	3.87e-06	0.000166	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—NFKB1—atherosclerosis	3.86e-06	0.000166	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MAPK8—atherosclerosis	3.8e-06	0.000163	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—AKT1—atherosclerosis	3.79e-06	0.000162	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—VEGFA—atherosclerosis	3.66e-06	0.000157	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—STAT3—atherosclerosis	3.63e-06	0.000156	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—VEGFA—atherosclerosis	3.58e-06	0.000154	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—STAT3—atherosclerosis	3.55e-06	0.000152	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—VEGFA—atherosclerosis	3.5e-06	0.00015	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—STAT3—atherosclerosis	3.47e-06	0.000149	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MAPK3—atherosclerosis	3.47e-06	0.000149	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MAPK3—atherosclerosis	3.39e-06	0.000145	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—TGFB1—atherosclerosis	3.36e-06	0.000144	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MAPK3—atherosclerosis	3.32e-06	0.000142	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—TGFB1—atherosclerosis	3.29e-06	0.000141	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—TGFB1—atherosclerosis	3.22e-06	0.000138	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IL6—atherosclerosis	3.18e-06	0.000136	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—AKT1—atherosclerosis	2.94e-06	0.000126	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IL6—atherosclerosis	2.53e-06	0.000109	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IL6—atherosclerosis	2.48e-06	0.000106	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IL6—atherosclerosis	2.42e-06	0.000104	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—AKT1—atherosclerosis	2.34e-06	0.0001	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—AKT1—atherosclerosis	2.29e-06	9.81e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—AKT1—atherosclerosis	2.24e-06	9.59e-05	CbGpPWpGaD
